Fundraising FoxRegor
Shanghai, CN · 4 known investors
Find your way into Regor
Sign up to see every warm intro you have to Regor
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Regor team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Regor is a drug discovery company that uses a computational platform (rCARD) to identify and optimize preclinical small-molecule candidates in metabolism, oncology, and immunology, which it licenses to pharmaceutical companies for clinical development. Its pipeline includes RGT-075, an oral GLP-1R agonist for obesity and type 2 diabetes, and next-generation CDK inhibitors for breast cancer.
Founders & leadership
Investors · 4
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: funding news · press coverage · the VCSheet dataset · Not right? Tell us
Vertex VenturesreportedPalo Alto · $500K – $10M
How we know: funding news · Not right? Tell us
Vertex Ventures ChinareportedSingapore
How we know: press coverage · Not right? Tell us
Frequently asked questions
- What does Regor do?
- Regor is a drug discovery company that uses a computational platform (rCARD) to identify and optimize preclinical small-molecule candidates in metabolism, oncology, and immunology, which it licenses to pharmaceutical companies for clinical development. Its pipeline includes RGT-075, an oral GLP-1R agonist for obesity and type 2 diabetes, and next-generation CDK inhibitors for breast cancer.
- Who founded Regor?
- Regor was founded by Xiayang Qiu.
- Who are Regor's investors?
- Regor's investors include LAV, Lilly Asia Ventures, Vertex Ventures, Vertex Ventures China.
- Where is Regor headquartered?
- Regor is headquartered in Shanghai, CN.